ArticleGland surgery2025
Association of thyroglobulin antibody and thyroid peroxidase antibody status with aggressive features in papillary thyroid carcinoma with Hashimoto's thyroiditis.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Predictive value of conventional ultrasonographic features combined with clinical factors for capsular invasion in papillary thyroid carcinoma with Hashimoto's thyroiditis.American journal of cancer research · 2026Article
- Hashimoto's thyroiditis both promotes and protects against papillary thyroid cancer.Frontiers in endocrinology · 2026Review
- The diagnostic efficacy of serum galectin-3 and other markers in papillary thyroid carcinoma.Gland surgery · 2025Article
- Sphingolipid Metabolism in the Pathogenesis of Hashimoto's Thyroiditis.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb) are thought to be linked to the development and prognosis of papillary thyroid carcinoma (PTC) combined with Hashimoto's thyroiditis (HT). However, the association between TgAb and TPOAb statuses and aggressive features in PTC with HT remains unclear. This study aims to elucidate the invasive or protective effects of different TgAb and TPOAb statuses in PTC patients with HT. Methods: A total of 317 patients who were pathologically diagnosed with PTC and HT were enrolled in this retrospective study. Data on preoperative serum TgAb, TPOAb, and thyroid hormone levels, as well as histopathological and ultrasound characteristics, were collected and analyzed. Based on TgAb and TPOAb status, patients were divided into four groups. The Kruskal-Wallis H test and Pearson chi-squared test were applied to compare aggressive features between the groups. Results: In our study, we enrolled 317 patients, who were divided into four groups based on TgAb and TPOAb status. Significant differences were found between groups in tumor size >4 cm (P=0.004), the number of central lymph node metastases (NCLNM, P=0.01), the central lymph node metastasis ratio (CLNMR, P=0.03), and the lateral lymph node metastasis ratio (LLNMR, P=0.01). Then we conducted pairwise comparisons between groups, which showed that the TgAb and TPOAb double-negative (TAb Conclusions: The TAb
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.